To test this possibility, we used the two genetic approaches we employed before, GADD34 CA-AAV transduction and eIF2α S51A knockin mice, to reduce p-eIF2α levels in cerebral neurons of the 5XFAD transgenic (Tg) mouse model of amyloidosis [51]. The gene discussed is EIF2A; the disease is amyloidosis.